• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Reocclusion (1985)
Event Date 03/25/2019
Event Type  Injury  
Event Description
It was reported that in-stent restenosis occurred.The patient was enrolled in the eminent clinical study.On (b)(6) 2018 the index procedure was performed.The target lesion was located in the right distal superficial femoral artery (sfa).It had a 5.5mm reference vessel diameter proximally and distally.The total length was 60mm visually estimated.The target lesion was 100% occluded and crossed through the true lumen.Two balloons were used for pre-dilation, and afterwards a 6mm x 80 mm eluvia study stent was implanted.Post-dilation was performed using two balloons and the residual stenosis was 5%.On (b)(6) 2019 in-stent restenosis of the target lesion was observed.On (b)(6) 2019 the patient was hospitalized and an interventional procedure of the target lesion was performed.Revascularization of the target lesion was achieved through rotarex, atherectomy and drug-coated balloon treatment.The patient was discharged on (b)(6) 2019.The investigator assessed this event as serious, not related to the index procedure, possibly related to the device and as anticipated.It was assessed as resolved on (b)(6) 2019.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC IRELAND LIMITED
ballybrit business park
galway
EI  
Manufacturer Contact
sonali arangil
two scimed place
maple grove, MN 55311
6515827403
MDR Report Key8535955
MDR Text Key142632626
Report Number2134265-2019-03484
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 04/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/22/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/05/2019
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0021753956
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/25/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age60 YR
-
-